540 related articles for article (PubMed ID: 31074184)
1. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
[TBL] [Abstract][Full Text] [Related]
2. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload.
Verbrugge FH; Dupont M; Bertrand PB; Nijst P; Penders J; Dens J; Verhaert D; Vandervoort P; Tang WH; Mullens W
Acta Cardiol; 2015 Jun; 70(3):265-73. PubMed ID: 26226699
[TBL] [Abstract][Full Text] [Related]
3. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
[TBL] [Abstract][Full Text] [Related]
4. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Mullens W; Dauw J; Martens P; Verbrugge FH; Nijst P; Meekers E; Tartaglia K; Chenot F; Moubayed S; Dierckx R; Blouard P; Troisfontaines P; Derthoo D; Smolders W; Bruckers L; Droogne W; Ter Maaten JM; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M;
N Engl J Med; 2022 Sep; 387(13):1185-1195. PubMed ID: 36027559
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial.
Martens P; Verbrugge FH; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Heylen L; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
Eur Heart J; 2023 Jun; 44(22):1995-2005. PubMed ID: 37138385
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Mullens W; Dauw J; Martens P; Meekers E; Nijst P; Verbrugge FH; Chenot F; Moubayed S; Dierckx R; Blouard P; Derthoo D; Smolders W; Ector B; Hulselmans M; Lochy S; Raes D; Van Craenenbroeck E; Vandekerckhove H; Hofkens PJ; Goossens K; Pouleur AC; De Ceuninck M; Gabriel L; Timmermans P; Prihadi EA; Van Durme F; Depauw M; Vervloet D; Viaene E; Vachiery JL; Tartaglia K; Ter Maaten JM; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
Eur J Heart Fail; 2022 Sep; 24(9):1601-1610. PubMed ID: 35733283
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome.
Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
Acta Cardiol; 2019 Apr; 74(2):100-107. PubMed ID: 29587582
[TBL] [Abstract][Full Text] [Related]
8. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
Verbrugge FH; Martens P; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W
J Am Coll Cardiol; 2023 May; 81(20):2013-2024. PubMed ID: 37197845
[TBL] [Abstract][Full Text] [Related]
10. Sodium and potassium changes during decongestion with acetazolamide - A pre-specified analysis from the ADVOR trial.
Dhont S; Martens P; Meekers E; Dauw J; Verbrugge FH; Nijst P; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
Eur J Heart Fail; 2023 Aug; 25(8):1310-1319. PubMed ID: 37062871
[TBL] [Abstract][Full Text] [Related]
11. Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial.
Ter Maaten JM; Beldhuis IE; van der Meer P; Krikken JA; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Damman K
Eur J Heart Fail; 2022 Feb; 24(2):385-392. PubMed ID: 34791756
[TBL] [Abstract][Full Text] [Related]
12. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
Ter Maaten JM; Rao VS; Hanberg JS; Perry Wilson F; Bellumkonda L; Assefa M; Sam Broughton J; D'Ambrosi J; Wilson Tang WH; Damman K; Voors AA; Ellison DH; Testani JM
Eur J Heart Fail; 2017 Aug; 19(8):1014-1022. PubMed ID: 28105769
[TBL] [Abstract][Full Text] [Related]
13. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
Hanberg JS; Rao V; Ter Maaten JM; Laur O; Brisco MA; Perry Wilson F; Grodin JL; Assefa M; Samuel Broughton J; Planavsky NJ; Ahmad T; Bellumkonda L; Tang WH; Parikh CR; Testani JM
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507113
[TBL] [Abstract][Full Text] [Related]
14. Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial.
Ter Maaten JM; Beldhuis IE; van der Meer P; Krikken JA; Postmus D; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Damman K
Nat Med; 2023 Oct; 29(10):2625-2632. PubMed ID: 37640861
[TBL] [Abstract][Full Text] [Related]
15. Post-diuretic spot urine sodium assessment in acute heart failure: a retrospective analysis.
Colson L; Vanhentenrijk S; Kalpakos T; Roosens B; Von Kemp B; Balthazar T; Lochy S; Verbrugge FH
Acta Clin Belg; 2024 Apr; 79(2):103-112. PubMed ID: 38613319
[TBL] [Abstract][Full Text] [Related]
16. Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.
Wilcox CS; Shen W; Boulton DW; Leslie BR; Griffen SC
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440005
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction.
Llàcer P; Núñez J; Croset F; García M; Fabregate M; Ruiz R; López G; Fernández C; Del Hoyo B; Campos J; Gomis A; Manzano L
Clin Cardiol; 2023 Aug; 46(8):906-913. PubMed ID: 37287326
[TBL] [Abstract][Full Text] [Related]
19. A review regarding the article 'Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure'.
Li K; Shi R; Luo L
Curr Probl Cardiol; 2024 Aug; 49(8):102688. PubMed ID: 38821235
[TBL] [Abstract][Full Text] [Related]
20. Diuretic response and effects of diuretic omission in ambulatory heart failure patients on chronic low-dose loop diuretic therapy.
Dauw J; Martens P; Tersalvi G; Schouteden J; Deferm S; Gruwez H; De Moor B; Nijst P; Dupont M; Mullens W
Eur J Heart Fail; 2021 Jul; 23(7):1110-1119. PubMed ID: 33641220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
